|

Pirfenidone Clinical Trials

2 actively recruiting trials across 1 location

Also known as: AiSiRui, PFD

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • Hubei Cancer Hospital1

Indications

  • Multiple Sclerosis1
  • Lung Cancer1
  • Cancer1

Other1 trial

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
Phase 2

Bethesda, Maryland1 trial

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.